Increase in the Expression of CD4+CD25+ Lymphocytic T Cells in the Indeterminate Clinical Form of Human Chagas Disease After Stimulation With Recombinant Antigens of Trypanosoma cruzi

被引:4
|
作者
de Moura Braz, Suellen Carvalho [1 ]
de Melo, Adriene Siqueira [1 ]
Aureliano de Melo Cavalcanti, Maria da Gloria [2 ,3 ]
Martins, Silvia Marinho [2 ,3 ]
de Oliveira, Wilson, Jr. [2 ,3 ]
da Silva, Edimilson Domingos [2 ,4 ]
Pinto Ferreira, Antonio Gomes [2 ,4 ]
Barros de Lorena, Virginia Maria [1 ,2 ]
Gomes, Yara de Miranda [1 ,5 ]
机构
[1] Programa Integrado Doenca Chagas Fiocruz, Dept Imunol, Rio De Janeiro, Brazil
[2] Programa Integrado Doenca Chagas Fiocruz, Rio De Janeiro, Brazil
[3] Univ Pernambuco UPE, Ambulatorio Doenca Chagas & Insuficiencia Cardiac, Recife, PE, Brazil
[4] Biomanguinhos Fiocruz, Rio De Janeiro, Brazil
[5] Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisas Aggeu Magalhaes CPqAM, Dept Imunol, BR-50670420 Recife, PE, Brazil
关键词
Chronic Chagas Disease; repetitive antigens; CD4+CD25+T cells; immunomodulation; IMMUNOLOGICAL SELF-TOLERANCE; IN-VITRO STIMULATION; LIMITED ROLE; INFECTION; CD8(+); CRA; CARDIOMYOPATHY; ANTIBODIES; FREQUENCY; PROTEINS;
D O I
10.1007/s10875-014-0092-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells are involved in the clinical course of chronic Chagas disease, possibly because they exercise a control in the patient's inflammatory response to Trypanosoma cruzi. This study analyzed the levels of CD4 + CD25+ T cells in chronic Chagas disease patients after in vitro stimulation of the peripheral blood mononuclear cells with CRA (Cytoplasmic Repetitive Antigen) or FRA (Flagellar Repetitive Antigen) T. cruzi antigens. Groups of patients with the cardiac form and indeterminate form; and non-infected individuals, were selected. The CD4 + CD25+ T lymphocyte population, as well as the FoxP3 expression and the IL10 production, were evaluated by flow cytometry after stimulation with CRA or FRA. The IND group presented higher levels of CD4 + CD25+ T cells than the CARD group. However, there was no evidence of a relationship between FoxP3 and IL10 with any of the chronic forms. Our results suggest the possible involvement of CD4 + CD25+ T cells specific to CRA and FRA in controlling the progression of clinical outcomes. Though, further studies are needed to define which mechanisms activate regulatory T cells and lead to pathology control in chronic human Chagas disease.
引用
收藏
页码:991 / 998
页数:8
相关论文
共 50 条
  • [1] Increase in the Expression of CD4 + CD25+ Lymphocytic T Cells in the Indeterminate Clinical Form of Human Chagas Disease After Stimulation With Recombinant Antigens of Trypanosoma cruzi
    Suellen Carvalho de Moura Braz
    Adriene Siqueira de Melo
    Maria da Glória Aureliano de Melo Cavalcanti
    Sílvia Marinho Martins
    Wilson de Oliveira
    Edimilson Domingos da Silva
    Antonio Gomes Pinto Ferreira
    Virginia Maria Barros de Lorena
    Yara de Miranda Gomes
    Journal of Clinical Immunology, 2014, 34 : 991 - 998
  • [2] Evaluation of CD4+CD25+ T lymphocyte response time kinetics in patients with chronic Chagas disease after in vitro stimulation with recombinant Trypanosoma cruzi antigens
    de Moura Braz, Suellen Carvalho
    Barros de Lorena, Virginia Maria
    Melo, Adriene Siqueira
    Aureliano Melo Cavalcanti, Maria da Gloria
    Gomes, Yara de Miranda
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2013, 46 (03) : 362 - 366
  • [3] The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection
    Mariano, Flavia S.
    Gutierrez, Fredy R. S.
    Pavanelli, Wander R.
    Milanezi, Cristiane M.
    Cavassani, Karen A.
    Moreira, Ana P.
    Ferreira, Beatriz R.
    Cunha, Fernando Q.
    Cardoso, Cristina R.
    Silva, Joao S.
    MICROBES AND INFECTION, 2008, 10 (07) : 825 - 833
  • [4] The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi
    Sales-Junior, Policarpo A.
    Golgher, Denise
    Oliveira, Roberta V.
    Vieira, Valeska
    Arantes, Rosa M. E.
    Lannes-Vieira, Joseli
    Gazzinelli, Ricardo T.
    MICROBES AND INFECTION, 2008, 10 (06) : 680 - 688
  • [5] Human CD4+CD25+ regulatory T cells
    Baecher-Allan, C
    Viglietta, V
    Hafler, DA
    SEMINARS IN IMMUNOLOGY, 2004, 16 (02) : 89 - 97
  • [6] Difference in gene expression profiles between human CD4+CD25+ and CD4+CD25- T cells
    Pati, N
    Ghosh, S
    Hessner, MJ
    Khoo, HJ
    Wang, XJ
    IMMUNOLOGY OF DIABETES II: PATHOGENESIS FROM MOUSE TO MAN, 2003, 1005 : 279 - 283
  • [7] CD4+CD25+ regulatory T cells in patients with acute lymphocytic leukemia
    Cao, Xiangshan
    Xie, Xiaobao
    Li, Aaihua
    Qiu, Guoqiang
    BLOOD, 2007, 110 (11) : 38B - 38B
  • [8] CD4+CD25+ regulatory T cells in health and disease
    Liu, HY
    Leung, BP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (5-6): : 519 - 524
  • [9] Isolation of human CD4+CD25+ regulatory T-cells for clinical trials
    Hoffmann, P
    Eder, R
    Piseshka, B
    Boeld, T
    Albrecht, J
    Doser, K
    Orso, E
    Dada, A
    Andreesen, R
    Holler, E
    Edinger, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S66 - S67
  • [10] Increase of CD4+CD25+ T cells in Smad3-/- mice
    Wang, Zi-Bing
    Cui, Yu-Fang
    Liu, Yu-Qing
    Jin, Wei
    Xu, Han
    Jiang, Zhu-Jun
    Lu, Ya-Xin
    Zhang, Ying
    Liu, Xiao-Lan
    Dong, Bo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (15) : 2455 - 2458